Perinatal management of fetal congenital heart disease in the era of COVID-19
Perinatal management of fetal congenital heart disease in the era of COVID-19
复制标题
COVID-19时代胎儿先天性心脏病的围产期管理
DOI：
10.1111/ped.14932
复制
发表时间：
2022
影响因子：
1.4
通讯作者：
Hikoro Matsui
中科院分区：
文献类型：
--
作者：
Hitomi Masuda;Ryo Inuzuka;Masatake Toshimitsu;Kohei Kashima;Hikoro Matsui
在出生后24小时、48小时和14天进行的COVID-19逆转录聚合酶链反应检测均显示阴性结果。由于在新生儿的整个分娩过程中，父母双方都是COVID-19阳性，他们通过电话更新，这使得病例管理更加困难。未来的病例可能会受益于基于网络的会议或视频通话，但这些远程系统需要由每家医院单独准备。[...]在父母感染COVID-19而无法使用常规方法的情况下，医院应制定替代方案，以获得知情同意，特别是在需要多种干预措施的冠心病病例中，如重症监护或导管和手术干预。5此外，需要新的条例和安全的官方系统，以便利用技术或数字通信获得知情同意。[...]重要的是要为患有CHD的胎儿制定围产期管理计划，以及让父母为COVID-19感染的可能性做好准备。
Reverse transcription-polymerase chain reaction tests for COVID-19 taken at 24 h, 48 h, and 14 days after birth all demonstrated negative results. Because both parents were COVID-19-positive throughout the course of the neonate's confinement, they were updated by telephone, which made the case management more difficult. Future cases may benefit from web-based meetings or video calls, but these remote systems need to be uniquely prepared by each hospital.[...] hospitals should have alternative protocols for acquiring informed consent in cases where parental COVID-19 infection prohibits conventional methods, particularly in cases such as CHD that require multiple interventions, such as intensive care or catheter and surgical interventions. 5 In addition, new regulations and a secure official system would be necessary to obtain informed consent using technological or digital communication.[...] it is important to plan perinatal management for fetuses with CHD, as well as to prepare the parents for the possibility of COVID-19 infection.